Search
Type
Audience
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 6 of 6 items.
… Authorization of COVISHIELD with English-only Vial and Carton Labels Starting … COVID-19 VACCINE (manufactured by AstraZeneca) are ChAdOx1-S recombinant vaccines developed by AstraZeneca and the …
AlertHealth professional risk communication | 2021-03-01
… AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with Thrombocytopenia Starting … affected AstraZeneca COVID-19 Vaccine, COVID-19 Vaccine (ChAdOx1-S [recombinant]) 5 mL solution for intramuscular injection, …
AlertHealth professional risk communication | 2021-03-24
… AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome Starting date: … affected AstraZeneca COVID-19 Vaccine, COVID-19 Vaccine (ChAdOx1-S [recombinant]) 5 mL solution for intramuscular injection, …
AlertHealth professional risk communication | 2021-06-29
… Health Canada issues label change on the AstraZeneca and COVISHIELD COVID-19 vaccines Starting date: April 14, 2021 … Last updated: 2021-06-29 Summary Product: AstraZeneca and COVISHIELD COVID-19 vaccines Issue: Health Canada is updating … including post-market updates, please visit Health Canada's COVID-19 vaccines and treatments portal . Original Advisory …
AlertPublic advisory | 2021-06-29
… which is available in French and English on Health Canada’s Drug Product Database , the federal government’s … affected AstraZeneca COVID-19 Vaccine, COVID-19 Vaccine (ChAdOx1-S [recombinant]), 5 mL solution for intramuscular … Health Canada issues label change on the AstraZeneca and COVISHIELD COVID-19 vaccines 2021-04-14 | Health products, …
AlertHealth professional risk communication | 2021-03-01
… which is available in French and English on Health Canada’s Drug Product Database , the federal government’s … and Supplier in Canada AstraZeneca COVID-19 Vaccine, (ChAdOx1-S [recombinant]) Suspension for Intramuscular … Health Canada issues label change on the AstraZeneca and COVISHIELD COVID-19 vaccines 2021-04-14 | Health products, …
AlertHealth professional risk communication | 2021-03-31